Suicidal Ideation Clinical Trial
Official title:
Peer Mentorship to Reduce Suicide Risk Following Psychiatric Hospitalization
Verified date | August 2017 |
Source | University of Michigan |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Every year in the United States about 1 million people make a suicide attempt and more than
38,000 die by suicide. The risk of suicide is highest among individuals with mental illness
who have been hospitalized due to suicidal thoughts or behaviors, yet there are few
interventions known to reduce suicide risk in this population. This study will develop and
pilot test a peer mentorship intervention by which trained peer professionals will use their
own personal experience with recovery from mental illness to instill hope and belongingness
in high-risk patients and provide additional support to prevent future suicidal thoughts or
behaviors.
The specific aims of the study are to: (1) develop a peer mentorship intervention to reduce
suicide risk among patients psychiatrically hospitalized with suicidal ideation or following
a suicide attempt; (2) Conduct a randomized controlled pilot study to assess the
acceptability, feasibility, and fidelity of the peer mentorship intervention in preparation
for a larger efficacy trial; and (3) an exploratory aim will be to measure potential
mediators and moderators of intervention effectiveness in terms of belongingness,
burdensomeness, and hopelessness according to the interpersonal theory of suicide.
Status | Completed |
Enrollment | 79 |
Est. completion date | May 26, 2017 |
Est. primary completion date | May 26, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: 1. are age 18 years or older 2. have medical record documentation of suicidal ideation or suicide attempt at the time of admission 3. are fluent in English Exclusion Criteria: 1. substantially cognitively impaired (according to Mini-Cog) 2. unable to provide voluntary, written, informed consent for any reason (including incompetency) 3. determined by the patient's attending psychiatrist that due to the patient's psychiatric condition peer mentorship may be harmful to the patient or peer specialist (e.g., severe personality disorder, unstable paranoia) 4. already receiving or intending to receive peer mentorship (including having a sponsor from Alcoholics Anonymous) or participate in group-based peer support on a biweekly or more frequent basis 5. are receiving electroconvulsive therapy (ECT) 6. are located more than 50 miles from any of the peer specialists 7. are being discharged to a residential treatment facility |
Country | Name | City | State |
---|---|---|---|
United States | University of Michigan Inpatient Psychiatry Unit | Ann Arbor | Michigan |
United States | Henry Ford Kingswood Hospital | Ferndale | Michigan |
Lead Sponsor | Collaborator |
---|---|
University of Michigan | National Institutes of Health (NIH) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Intervention acceptability (median number of peer mentorship contacts at 3 months post-discharge is at least 4, as well as by satisfaction questionnaires.) | Patients' willingness and satisfaction with participating in the intervention as a measure of intervention acceptability. Measured by at least 70% of participants in both study arms completing follow-up measures at 6 months, the median number of peer mentorship contacts at 3 months post-discharge is at least 4, as well as by satisfaction questionnaires. | 3 and 6 months post-baseline | |
Primary | Intervention feasibility (Study team's ability to deliver the intervention) | Study team's ability to deliver the intervention as a measure of feasibility. Measured by at least 50% of eligible patients choosing to enroll in the study, at least 80% of participants assigned to the peer mentorship arm meeting with a peer specialist prior to hospital discharge, at least 70% of participants in both study arms completing follow-up measures at 6 months, and the study meeting its enrollment goal of 60 patients in 12 months. | 3 and 6 months post-baseline | |
Secondary | Current suicidal ideation (measured by the Beck Suicide Scale (BSS) | Patient's current suicidal ideation as measured by the Beck Suicide Scale (BSS) | 3 and 6 months post-baseline | |
Secondary | Peak suicidal ideation (measured by the Columbia Suicide Severity Rating Scale (CSSR-S) | Patient's peak suicidal ideation since the last visit as measured by the Columbia Suicide Severity Rating Scale (CSSR-S) | 3 and 6 months post-baseline | |
Secondary | Suicide attempts (measured by the Columbia Suicide Severity Rating Scale) | Patient's suicide attempts since the last visit as measured by the Columbia Suicide Severity Rating Scale | 3 and 6 months post-baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05334381 -
Navigating Mental Health Treatment for Black Youth
|
N/A | |
Recruiting |
NCT04653337 -
Neuroimaging Guided and Robot-assisted rTMS for Suicidal Ideation of Depression
|
Phase 2 | |
Terminated |
NCT04254809 -
Evaluation of a Computerized Intervention for Learning to Re-Evaluate Suicidal Thoughts
|
N/A | |
Recruiting |
NCT05848089 -
Real-time Intervention for Suicide Risk Reduction
|
N/A | |
Recruiting |
NCT06322199 -
Differences Between Suicide Attempters and Suicide Ideators. Influence of the Brief Therapy Attempted Suicide Short Intervention Program (ASSIP) on Neuropsychological Correlates and Psychological Process Factors - Project 3
|
||
Completed |
NCT05280756 -
Home-based tDCS for Prevention of Suicidal Ideation
|
N/A | |
Not yet recruiting |
NCT06454136 -
Pilot Trial of Mobile Technology for Adolescent Suicidality
|
N/A | |
Completed |
NCT01944293 -
Ketamine for Suicidality in Bipolar Depression
|
Phase 1/Phase 2 | |
Completed |
NCT02021344 -
Mental Health First Aid for College Students
|
N/A | |
Not yet recruiting |
NCT04686162 -
Bae: A Smartphone Application for a Better Following Adolescents at Risk of Suicidal Behavior: Study of Acceptability and Preliminary Results of Efficacy
|
N/A | |
Recruiting |
NCT05377177 -
Cortical Inhibition as a Biomarker of Response in a Comparison of Bilateral Versus Unilateral Accelerated Theta Burst Stimulation for Suicidal Ideation in Treatment-Resistant Depression -COMBAT-SI
|
N/A | |
Completed |
NCT05580757 -
Pharmacists as Gate Keepers in Suicide Prevention: Needs of Pharmacists
|
||
Recruiting |
NCT05925322 -
Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality
|
N/A | |
Not yet recruiting |
NCT05427734 -
Treating Drivers of Suicide Using Jaspr Health
|
N/A | |
Recruiting |
NCT04112368 -
Cyclical Neuroactive Steroid Changes, Arousal, and Proximal Suicide Risk: An Experimental Approach
|
Phase 4 | |
Completed |
NCT04026308 -
Written vs Electronic Safety Planning Study
|
N/A | |
Recruiting |
NCT05537376 -
A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illness
|
N/A | |
Not yet recruiting |
NCT06311591 -
Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part B
|
N/A | |
Recruiting |
NCT05894980 -
How to Reduce Suicidal Thoughts and Impulsivity in Depression
|
N/A | |
Not yet recruiting |
NCT05860257 -
Transforming Adolescent Mental Health Through Accessible, Scalable, Technology-supported Small-group Instruction
|
N/A |